Bionexo exports technology for hospital purchase management to Europe

Bionexo is a reference in electronic hospital purchases in Brazil and in Argentina and is now expanding to Europe. The company, which is the largest in the sector in Latin America, exports services and a new culture in purchase management, having Spain as the springboard for this new region.

Transparency in the purchase process, agility, cost reduction and a new vision towards corporate posture and the benefits of online acquisition of medications and hospital material add up to a series of attributions that the global market can attain through Bionexo.

Counting on 700 hospitals in Spain, Bionexo's platform will represent a transformation in hospital purchase management with the modernization of the process.

Bionexo presented tools and means against hospital and supplier resistance toward online purchases. Previous experiences from unsuccessful companies have left a stigma in the market, which was only overcome by Bionexo's platform solutions.

According to Bionexo's executive Mauricio De Lazzari Barbosa, the European market takes other variables into account, for instance, the fact that Bionexo doesn't charge suppliers, the well-functioning of the network, and the performance of the electronic community Managing Council. As a result, the market was sensitive to the fact that online purchasing process is irreversible and is actually a great partner in the evolution of the healthcare sector. In Europe, the healthcare sector accumulates problems such as increasing demand and spending as a result of the aging population as well as a bottleneck in services availability, which brings about longer waiting lines.

Iberian Peninsula
Bionexo's expansion plan includes markets from other countries of the Iberian Peninsula, such as Portugal, and Latin America, in which it already is the leading hospital purchase community. This year the company started its operations in Spain, where it invested close to 1 million Euros (its own capital). Bionexo already operates in Brasil and in Argentina, and is planning on kicking off in the beginning of 2008 in Mexico. In the last year, Bionexo has witnessed a 25% increase in the transacted volume. In 2006, the financial activity amounted to US$ 270 million, and in 2007 it rose to US$ 335 million.

< back